Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Bacterial

Q fever

Q热

Q fever is a zoonotic infectious disease caused by Coxiella burnetii, a strict intracellular bacterial pathogen with noted antigenic phase variation [1][2]. The available sources describe a worldwide distribution with variable epidemiology and indicate that outbreaks and under-reporting have been observed in some settings [1][3]. Source-backed detail on the full clinical spectrum, prevention program specifics, and surveillance thresholds is not yet available [1][2][3].

Definition

Q fever is an infectious zoonosis caused by Coxiella burnetii [1][2]. The organism is described as an obligate or strict intracellular, Gram-negative bacterium with a high infection capacity, and it proliferates in an acidified intracellular compartment [1][2]. The sources also note antigenic phase variation linked to changes in membrane lipopolysaccharide complexity [1].

Clinical features

The sources describe two broad clinical presentations: an acute form, which is reported as more frequent and often asymptomatic, and a persistent focalized infection that occurs in about 4 to 5% of patients and is generally associated with poor evolution [1]. Another source notes that the clinical presentation depends on the virulence of the infecting strain and on patient-specific risk factors, and that persistent infection cannot exist without a focus of infection [2]. Infections are often subclinical, but severe and life-threatening complications may occur, and long-term sequelae can follow persistent infection [3]. More granular symptom-level detail is not yet available from the provided sources [1][2][3].

Epidemiology

Q fever is reported worldwide, with variable geographical distribution and epidemiological patterns that may include endemic, hyperendemic, and large epidemic outbreak settings [1][2]. One source notes a Scottish outbreak and another states that the organism has a worldwide distribution with the notable exception of New Zealand [3]. The disease is said to affect people in rural areas who are in contact with animals, and it is described as rarely reported despite its ubiquity, suggesting possible underdiagnosis or under-reporting [1][3].

Transmission

The most common human transmission route described in the sources is inhalation of aerosols containing the pathogen [1]. The aerosol risk is emphasized particularly for material formed from placental derivatives [1]. The organism’s host range includes arthropods, birds, and a diverse range of mammals, including livestock and companion animals, and these animals are identified as principal reservoirs alongside ticks [2][1].

Risk groups

The sources most clearly identify people in rural areas who are in contact with animals as a key affected group [1]. Occupational or exposure-related risk is also suggested for people working with animals or handling birth products [1]. Beyond these exposure-linked groups, the provided material does not supply enough source-backed detail to define additional high-risk populations with confidence [1][2].

Prevention

The provided sources do not give a complete prevention guideline or formal control package [1][2][3]. They do indicate that exposure minimization measures should be undertaken for people working with animals or handling birth products, which is consistent with the aerosol exposure described in the sources [1]. Source-backed detail on vaccination, post-exposure measures, or specific occupational protocols is not yet available [1].

Surveillance note

In surveillance terms, Q fever should be interpreted as a zoonotic bacterial infection with a wide animal reservoir and a transmission pattern dominated by aerosol exposure, especially around animal birth material [1][2]. The literature provided highlights variable geography, outbreak potential, and under-reporting, so apparent rarity should not be taken as evidence of absence [3]. The sources also emphasize that persistent focalized infection represents a distinct clinical pattern and that no persistent infection can exist without a focus, which may be relevant when interpreting prolonged or relapsing cases [2].

References
  1. 1 España PP et al. Q Fever (Coxiella Burnetii). Semin Respir Crit Care Med. 2020 Aug. PMID: 32629489. doi: 10.1055/s-0040-1710594. PubMed: https://pubmed.ncbi.nlm.nih.gov/32629489/
  2. 2 Eldin C et al. From Q Fever to Coxiella burnetii Infection: a Paradigm Change. Clin Microbiol Rev. 2017 Jan. PMID: 27856520. doi: 10.1128/CMR.00045-16. PubMed: https://pubmed.ncbi.nlm.nih.gov/27856520/
  3. 3 Cutler SJ et al. Q fever. J Infect. 2007 Apr. PMID: 17147957. doi: 10.1016/j.jinf.2006.10.048. PubMed: https://pubmed.ncbi.nlm.nih.gov/17147957/
  4. 4 Fevers. Herbs in the Treatment of Children. 2003. doi: 10.1016/b978-0-443-07163-8.50019-8. DOI: https://doi.org/10.1016/b978-0-443-07163-8.50019-8
  5. 5 Fevers. Crocologia – A Detailed Study of Saffron, the King of Plants. 2020. doi: 10.1163/9789004435292_024. DOI: https://doi.org/10.1163/9789004435292_024
  6. 6 Typhoid Fever (Paratyphoid Fever, Enteric Fever). Netter's Gastroenterology. 2010. doi: 10.1016/b978-1-4377-0121-0.50175-6. DOI: https://doi.org/10.1016/b978-1-4377-0121-0.50175-6
Coding Register
ICD-10
ICD-11
Key Statistics
Total cases
18K
Peak month
2019-01
Coverage
8 reporting countries · 2000-01-01 → 2026-06-20

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
2,068
Data Version
2026-06-20
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

AU
Australia NINDSSmonthlymicrosoft_bi

Australia

Australian national notifiable diseases surveillance dashboard.

Official source
CH
Switzerland FOPH IDDweeklyrest_api

Switzerland

Switzerland FOPH/BAG IDD mandatory reporting API normalized to national case rows. Monthly series may use the dashboard CHFL aggregate where CH-only monthly series are not exposed.

Official source
HK
Hong Kong, China CHP Notifiable Diseasesmonthlyopen_data_csv

Hong Kong, China

Hong Kong, China CHP annual notifiable infectious disease CSVs normalized to national monthly totals

Official source
JP
JP NIID Weeklyweeklyweb

Japan

Japan weekly infectious disease surveillance via NIID/JIHS.

Official source
KR
Korea KDCA EIDmonthlyopen_api_or_portal_download

South Korea

Korea KDCA notifiable infectious disease OpenAPI or portal/KOSIS downloads aggregated to national monthly notification counts.

Official source
NZ
phf_monthlymonthlyweb

New Zealand

PHF Science (formerly ESR) monthly notifiable disease surveillance data via internal globalID2 crawler

Official source
TW
Taiwan, China CDC NIDSSmonthlyopen_data_csv

Taiwan, China

Taiwan, China monthly notifiable infectious disease open-data CSV feed.

Official source
US
US CDC NNDSSweeklyapi

United States

CDC National Notifiable Diseases Surveillance System provisional data.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.